X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47738) 47738
Publication (4303) 4303
Newsletter (845) 845
Book Review (791) 791
Book Chapter (350) 350
Book / eBook (321) 321
Conference Proceeding (84) 84
Dissertation (47) 47
Magazine Article (27) 27
Data Set (11) 11
Newspaper Article (7) 7
Web Resource (5) 5
Paper (4) 4
Transcript (4) 4
Government Document (3) 3
Trade Publication Article (3) 3
Presentation (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29650) 29650
male (24304) 24304
index medicus (23517) 23517
stroke (17614) 17614
female (17179) 17179
animals (13893) 13893
clinical neurology (13649) 13649
neurosciences (13360) 13360
middle aged (12673) 12673
aged (11930) 11930
adult (8098) 8098
rats (8033) 8033
ischemia (8025) 8025
brain (7510) 7510
neurology (6931) 6931
treatment outcome (6518) 6518
risk factors (6062) 6062
cerebral infarction (5669) 5669
magnetic resonance imaging (5475) 5475
surgery (5403) 5403
cerebral ischemia (5199) 5199
peripheral vascular disease (4902) 4902
disease models, animal (4799) 4799
aged, 80 and over (4723) 4723
time factors (4190) 4190
rats, sprague-dawley (3887) 3887
analysis (3763) 3763
neuroprotection (3734) 3734
care and treatment (3707) 3707
research (3666) 3666
retrospective studies (3551) 3551
brain - pathology (3539) 3539
tomography, x-ray computed (3389) 3389
mice (3378) 3378
focal cerebral-ischemia (3372) 3372
infarction (3218) 3218
medicine & public health (3203) 3203
brain ischemia - drug therapy (3134) 3134
mortality (3034) 3034
therapy (2948) 2948
health aspects (2928) 2928
cerebral-ischemia (2876) 2876
cerebral angiography (2787) 2787
prognosis (2758) 2758
brain ischemia - pathology (2678) 2678
acute ischemic-stroke (2619) 2619
radiology, nuclear medicine & medical imaging (2582) 2582
pharmacology & pharmacy (2579) 2579
stroke - drug therapy (2565) 2565
apoptosis (2556) 2556
inflammation (2470) 2470
neuroimaging (2463) 2463
cerebral blood flow (2455) 2455
article (2437) 2437
patients (2365) 2365
cardiovascular diseases (2306) 2306
diagnosis (2306) 2306
follow-up studies (2296) 2296
risk (2283) 2283
reperfusion (2269) 2269
neurosurgery (2249) 2249
ischemic stroke (2219) 2219
prospective studies (2214) 2214
subarachnoid hemorrhage (2213) 2213
stroke - etiology (2212) 2212
adolescent (2192) 2192
thrombolysis (2172) 2172
hemorrhage (2164) 2164
neuroprotective agents - pharmacology (2146) 2146
medicine (2140) 2140
neurons (2079) 2079
disease (2074) 2074
stroke - pathology (2067) 2067
oxidative stress (2052) 2052
rats, wistar (2052) 2052
brain ischemia - physiopathology (2042) 2042
stroke - physiopathology (2040) 2040
cerebral infarction - etiology (1991) 1991
hypertension (1975) 1975
thrombolytic therapy (1972) 1972
rodents (1969) 1969
stroke - therapy (1957) 1957
neuroprotective agents - therapeutic use (1924) 1924
injury (1895) 1895
medical research (1879) 1879
management (1822) 1822
expression (1798) 1798
injuries (1798) 1798
intracerebral hemorrhage (1791) 1791
occlusion (1789) 1789
cerebral-artery occlusion (1773) 1773
infarction, middle cerebral artery - pathology (1764) 1764
artery occlusion (1756) 1756
child (1752) 1752
brain - metabolism (1751) 1751
cell biology (1740) 1740
infarction, middle cerebral artery - drug therapy (1724) 1724
brain ischemia - complications (1723) 1723
brain ischemia - metabolism (1723) 1723
hematology (1722) 1722
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (237) 237
OISE - Stacks (13) 13
UTL at Downsview - May be requested (13) 13
UofT at Mississauga - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Online Resources - Online (11) 11
Holland Bloorview Kids Rehabilitation - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Baycrest Hospital - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
West Park Healthcare Centre - Stacks (5) 5
UofT at Scarborough - Stacks (3) 3
OISE - Lost (2) 2
Providence Healthcare - Reference (2) 2
Robarts - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
St. Michael's Hospital - Stacks (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46652) 46652
Japanese (723) 723
German (637) 637
Chinese (327) 327
French (263) 263
Spanish (257) 257
Russian (87) 87
Dutch (40) 40
Korean (30) 30
Norwegian (26) 26
Polish (26) 26
Portuguese (23) 23
Italian (19) 19
Swedish (17) 17
Danish (15) 15
Finnish (13) 13
Czech (10) 10
Serbian (9) 9
Hungarian (7) 7
Turkish (7) 7
Slovak (5) 5
Hebrew (3) 3
Icelandic (3) 3
Arabic (2) 2
Croatian (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1021 - 1031
Patients with acute STEMI undergoing PCI were assigned to cyclosporine or placebo. No significant between-group difference was seen in the rate of death,... 
HEART | MEDICINE, GENERAL & INTERNAL | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | INJECTION | REPERFUSION INJURY | SIZE | PORE | ISCHEMIA | CARDIOPROTECTION | ASPIRATION | Enzyme Inhibitors - adverse effects | Injections, Intravenous | Double-Blind Method | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Enzyme Inhibitors - administration & dosage | Cyclophilins - antagonists & inhibitors | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Electrocardiography | Female | Aged | Heart Failure - epidemiology | Ventricular Remodeling - drug effects | Percutaneous Coronary Intervention | Care and treatment | Usage | Angiography | Heart enlargement | Dosage and administration | Cyclosporine | Heart attack | Occlusion | Myocardial infarction | Heart | Cerebral infarction | Heart attacks | Intravenous administration | Cyclosporins | Angioplasty | Body weight | Coronary artery | Clinical trials | Angina | Patients | Clinical outcomes | Reperfusion | Ventricle | Drug therapy | Heart diseases | Pharmaceuticals | Life Sciences | Bioengineering | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The Lancet, ISSN 0140-6736, 04/2018, Volume 391, Issue 10131, pp. 1693 - 1705
Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically... 
MECHANICALLY VENTILATED PATIENTS | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | 2015 INTERNATIONAL CONSENSUS | CARDIOVASCULAR CARE SCIENCE | SURGICAL SITE INFECTION | SUPPLEMENTAL OXYGEN | ELEVATION MYOCARDIAL-INFARCTION | CARDIOPULMONARY-RESUSCITATION | PERIOPERATIVE OXYGEN | ABDOMINAL-SURGERY | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Pneumonia - therapy | Oxygen - therapeutic use | Humans | Middle Aged | Cross Infection - mortality | Male | Sepsis - complications | Conservative Treatment - methods | Oxygen - adverse effects | Cross Infection - complications | Hospital Mortality - trends | Myocardial Infarction - therapy | Oxygen - supply & distribution | Pneumonia - mortality | Aged, 80 and over | Iatrogenic Disease - epidemiology | Adult | Female | Oxygen Inhalation Therapy - methods | Length of Stay - statistics & numerical data | Oxygen Inhalation Therapy - mortality | Cross Infection - epidemiology | Morbidity - trends | Cross Infection - therapy | Pneumonia - epidemiology | Sepsis - epidemiology | Randomized Controlled Trials as Topic | Sepsis - mortality | Critical Illness - epidemiology | Myocardial Infarction - complications | Oxygen Inhalation Therapy - adverse effects | Sepsis - therapy | Critical Illness - therapy | Pneumonia - complications | Aged | Medical research | Pneumonia | Bacterial pneumonia | Mortality | Morbidity | Analysis | Cardiac patients | Medicine, Experimental | Medical care | Adults | Cross infection | Nosocomial infections | Health aspects | Quality management | Myocardial infarction | Hyperbaric oxygen therapy | Therapy | Intensive care | Prospero protein | Clinical trials | Life assessment | Systematic review | Subgroups | Habitability | Randomization | Surgery | Heart diseases | Emergency medical services | Respiratory therapy | Evaluation | Cerebral infarction | Oxygen | Stroke | Sensitivity analysis | Patients | Trauma | Disease control | Meta-analysis | Respiratory diseases | Sepsis | Infarction | Quality assessment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 17, pp. 1587 - 1597
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1287 - 1296
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 25, pp. 2419 - 2432
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 21, pp. 2205 - 2217
Immediate percutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarction. In this study, PCI that was... 
IMMEDIATE ANGIOPLASTY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | 30-DAY MORTALITY | INTRAVENOUS THROMBOLYTIC THERAPY | RISK PATIENTS | REPERFUSION THERAPY | SYMPTOM-ONSET | PRIMARY ANGIOPLASTY | FIBRINOLYTIC THERAPY | Myocardial Infarction - mortality | Myocardial Infarction - classification | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Female | Cerebral Infarction - chemically induced | Double-Blind Method | Kaplan-Meier Estimate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Myocardial Infarction - complications | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Care and treatment | Abciximab | Coronary artery bypass | Comparative analysis | Health aspects | Heart attack | Angioplasty | Heart attacks | Intubation | Index Medicus | Abridged Index Medicus
Journal Article